| Zika Virus RNA (8000101271) | |
|---|---|
| Test Mnemonic: | |
| Specimen Requirements: | |
| Collection: | Routine venipuncture, neat urine |
| Container: | Serum tubes, SST, PPT, EDTA, ACD-A, NAC; urine in sterile container or aliquot in Aptima Urine Transport Tube |
| Minimum Volume: | 2 mL serum or plasma; 2 mL urine |
| Storage/Transport: | Transport to the lab as soon as possible. If transport is delayed, refrigerate sample. |
| Stability: | Urine must be transferred to an Aptima Urine Transport Tube within 72 hours of collection. |
| Causes for Rejection: | Mislabeled or unlabeled, leaking specimen |
| Reference Range: | Negative |
| Turnaround Time: | Batch testing is performed 2 times a week. |
| Methodology: | Transcription-Mediated Amplification with Hybridization Protection Assay |
| Performed: | Clinical Microbiology |
| Synonyms: | Zika RT-PCR |
| Clinical Indication: | Suspected infection or exposure to the Zika virus. |
| CPT 4 Code: | 87798 |
| Note: | This test has been cleared for use under the FDA Emergency Use Authorization (EUA). It has not been cleared by the FDA. |
| When ordering tests for which Medicare or Medicaid reimbursement will be sought, physicians should only order tests that are medically necessary for the diagnosis or treatment of the patient. Components of the organ or disease panels may be ordered individually. The diagnostic information must substantiate all tests ordered and must be in the form of an ICD-10 code or its verbal equivalent. | |